Incannex Healthcare Inc. Cash And Cash Equivalents
Incannex Healthcare Inc. (IXHL) had Cash And Cash Equivalents of $33.36 million as of 2023-06-30, per its 20-F filed 2023-10-31.
Discontinued › Assets › Cash and Cash Equivalent
ifrs-full:CashAndCashEquivalents · last filed 2023-10-31
- 2023-06-30: Cash And Cash Equivalents $33.36M.
- 2022-12-31: Cash And Cash Equivalents $41.42M.
- 2022-06-30: Cash And Cash Equivalents $37.50M.
- 2021-12-31: Cash And Cash Equivalents $19.77M.
| Period end | Cash And Cash Equivalents |
|---|---|
| 2023-06-30 | $33.36M 20-F · filed 2023-10-31 |
| 2022-12-31 | $41.42M 6-K · filed 2023-02-27 |
| 2022-06-30 | $37.50M 20-F · filed 2023-10-31 |
| 2021-12-31 | $19.77M 6-K · filed 2023-02-27 |
| 2021-06-30 | $9.12M 20-F · filed 2023-10-31 |
| 2020-06-30 | $3.60M 20-F · filed 2023-10-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B |